Skip to content

Carotid Atherosclerosis in Patients With Aortic Coarctation

Carotid Atherosclerosis in Patients With Aortic Coarctation

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT03999073
Acronym
CoA
Enrollment
116
Registered
2019-06-26
Start date
2012-01-31
Completion date
2019-01-31
Last updated
2019-06-26

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Atherosclerosis, Aortic Coarctation

Brief summary

Despite aortic coarctation (CoA) repair these patients have cardiovascular complications and coronary artery disease is the most common cause of death.

Detailed description

The aim with this study was to measure intima-media thickness (IMT) and plaques in arteries compared to cardiovascular markers in controls and patients with CoA.

Interventions

Ultrasound measurement

Sponsors

Skane University Hospital
Lead SponsorOTHER

Study design

Observational model
CASE_CONTROL
Time perspective
OTHER

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
Yes

Inclusion criteria

* sex and age-matched controls

Exclusion criteria

* acute and chronic inflammation disease, underlying malignancies and diabetes mellitus.

Design outcomes

Primary

MeasureTime frameDescription
Intima-media thicknessIntima-media thickness will be measured at one time point namely at inclusion. Data will be reported when study is completed, an average of 2 year.Measurement in mm

Secondary

MeasureTime frameDescription
Cardiovascular markersBlood samples will be taken at one time point namely at inclusion. Then biomarkers will be analysed when study is completed. Data will be reported when study is completed, an average of 2 year.A multiplex platform to analyze circulating blood levels biomarkers was used.

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026